Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeHealth

      Health

      ThermoGenesis Holdings to Present at the H.C. Wainwright 24th Annual Global Investment Conference
      Health

      ThermoGenesis Holdings to Present at the H.C. Wainwright 24th Annual Global Investment Conference

      September 8, 2022
      Unilever, Reckitt, Estée Lauder, Nestlé, BASF, and Evonik to Speak at Veeva’s Virtual Summit for Consumer Goods and Chemical Industries
      Health

      Unilever, Reckitt, Estée Lauder, Nestlé, BASF, and Evonik to Speak at Veeva’s Virtual Summit for Consumer Goods and Chemical Industries

      September 8, 2022
      West to Participate in Upcoming Investor Conference
      Health

      West to Participate in Upcoming Investor Conference

      September 8, 2022
      Biora Therapeutics to Participate in Upcoming H.C. Wainwright Investment Conference
      Health

      Biora Therapeutics to Participate in Upcoming H.C. Wainwright Investment Conference

      September 6, 2022
      Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX(TM) LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option
      Health

      Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX(TM) LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option

      September 6, 2022
      Cardinal Health Announces Governance Enhancements and Shareholder Value Creation Initiatives
      Health

      Cardinal Health Announces Governance Enhancements and Shareholder Value Creation Initiatives

      September 6, 2022
      Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candidate
      Health

      Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candidate

      September 6, 2022
      Tonix Pharmaceuticals Announces Oral Presentations Involving TNX-1500 (Fc-Modified Anti-CD40L mAb) at the International Congress of The Transplantation Society (TTS 2022)
      Health

      Tonix Pharmaceuticals Announces Oral Presentations Involving TNX-1500 (Fc-Modified Anti-CD40L mAb) at the International Congress of The Transplantation Society (TTS 2022)

      September 6, 2022
      Astellas Announces Topline Results from Phase 3 Long-Term Safety Study of Fezolinetant in Mainland China
      Health

      Astellas Announces Topline Results from Phase 3 Long-Term Safety Study of Fezolinetant in Mainland China

      September 5, 2022
      Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports
      Health

      Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports

      September 5, 2022
      « 1 … 226 227 228 229 230 … 247 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026